Picture of RetinalGenix Technologies logo

RTGN RetinalGenix Technologies Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Momentum

Relative Strength (%)
1m-4.04%
3m-36.47%
6m-70.51%
1yr-70.1%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w Highn/a
50d MAn/a
200d MAn/a

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capitaln/a
Return on Equityn/a
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of RetinalGenix Technologies EPS forecast chart

Profile Summary

RetinalGenix Technologies Inc. is an ophthalmic research and development company. The Company is focused on developing technologies to screen, monitor, diagnose and treat ocular, optical, and sight-threatening disorders. The Company is engaged to treat vision loss and blindness due to diabetic retinopathy and maculopathy through two devices: Retinal Imaging Screening Device, a portable, retinal imaging system providing a 200-degree field of view without requiring pupil dilation; and RetinalCam, a home monitoring retinal imaging device and physician alert system offering real-time communication with physicians available 24/7. RetinalCam, is anticipated to have the capability to be used by patients in a variety of locations, including at home, primary care centers, emergency rooms and telehealth centers and nursing homes. Its Retinal Imaging Screening Device technology enables high-risk individuals to send their physician digitized retinal images and stream video easily from their homes.

Directors

    Last Annual
    December 31st, 2022
    Last Interim
    September 30th, 2023
    Incorporated
    November 17th, 2017
    Public Since
    January 7th, 2022
    Sector
    Biotechnology & Medical Research
    Industry
    Healthcare
    Exchange
    us flag iconPink Sheets on Nasdaq
    Shares in Issue
    17,635,478

    RTGN Share Price Performance

    Upcoming Events for RTGN

    Similar to RTGN

    Picture of Acura Pharmaceuticals logo

    Acura Pharmaceuticals

    us flag iconPink Sheets on Nasdaq

    Picture of Adhera Therapeutics logo

    Adhera Therapeutics

    us flag iconPink Sheets on Nasdaq

    Picture of Ramoil Management logo

    Ramoil Management

    us flag iconPink Sheets on Nasdaq

    Picture of Adynxx logo

    Adynxx

    us flag iconPink Sheets on Nasdaq

    Picture of Aeolus Pharmaceuticals logo

    Aeolus Pharmaceuticals

    us flag iconPink Sheets on Nasdaq

    FAQ